These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11918520)

  • 21. Cyclooxygenase-2 and prostaglandins in articular tissues.
    Martel-Pelletier J; Pelletier JP; Fahmi H
    Semin Arthritis Rheum; 2003 Dec; 33(3):155-67. PubMed ID: 14671726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [COX-2 inhibitor to whom?].
    Martio J
    Duodecim; 2000; 116(12):1265-7. PubMed ID: 11988961
    [No Abstract]   [Full Text] [Related]  

  • 23. [Role of cyclooxygenase-2 (COG-2) in the etiology of pain].
    Nasonova VA
    Ter Arkh; 2001; 73(5):56-7. PubMed ID: 11517752
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of the baseline cardiovascular risk profile among hypertensive patients prescribed COX-2-specific inhibitors or nonspecific NSAIDs: data from real-life practice.
    Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC
    Am J Manag Care; 2002 Oct; 8(15 Suppl):S392-400. PubMed ID: 12416789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defining COX-2 inhibitors.
    Lipsky PE
    J Rheumatol Suppl; 2000 Oct; 60():13-6. PubMed ID: 11032097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An introduction to aspirin, NSAIDs, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part I.
    Moyad MA
    Semin Urol Oncol; 2001 Nov; 19(4):294-305. PubMed ID: 11769881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of tramadol/acetaminophen tablets (Ultracet) as add-on therapy for osteoarthritis pain in subjects receiving a COX-2 nonsteroidal antiinflammatory drug: a multicenter, randomized, double-blind, placebo-controlled trial.
    Emkey R; Rosenthal N; Wu SC; Jordan D; Kamin M;
    J Rheumatol; 2004 Jan; 31(1):150-6. PubMed ID: 14705234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coxibs: Evolving role in pain management.
    Katz N
    Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):15-24. PubMed ID: 12528070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COX-2 inhibitors.
    Brooks PM; Day RO
    Med J Aust; 2000 Oct; 173(8):433-6. PubMed ID: 11090038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Celecoxib: a COX-2 inhibitor.
    Andrews SA; Wallace CK; Davis RL
    Am J Manag Care; 1999 Apr; 5(4):511-8; quiz 522-4. PubMed ID: 10387389
    [No Abstract]   [Full Text] [Related]  

  • 31. Nephrotoxic potential of selective cyclooxygenase-2 inhibitors.
    Sandhu GK; Heyneman CA
    Ann Pharmacother; 2004 Apr; 38(4):700-4. PubMed ID: 14982980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osteoarthritis: a review of treatment options.
    Seed SM; Dunican KC; Lynch AM
    Geriatrics; 2009 Oct; 64(10):20-9. PubMed ID: 20726384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [New nonsteroidal antirheumatic drugs].
    Forster A; Michel BA
    Praxis (Bern 1994); 2000 May; 89(20):855-60. PubMed ID: 10865508
    [No Abstract]   [Full Text] [Related]  

  • 34. [COX-2 inhibitor in arthrosis. Discontinuation before operations not necessary].
    MMW Fortschr Med; 2001 Oct; 143(42):64. PubMed ID: 11697296
    [No Abstract]   [Full Text] [Related]  

  • 35. COX-2 selective inhibitors in the treatment of osteoarthritis.
    Laine L; White WB; Rostom A; Hochberg M
    Semin Arthritis Rheum; 2008 Dec; 38(3):165-87. PubMed ID: 18177922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cox-2 inhibitors: a new class of medication?
    Habershaw TA
    Med Health R I; 1999 Sep; 82(9):332-4. PubMed ID: 10517079
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of NSAIDs, COX-2 inhibitors, and acetaminophen and associated coprescriptions of gastroprotective agents in an elderly population.
    Rahme E; Marentette MA; Kong SX; Lelorier J
    Arthritis Rheum; 2002 Dec; 47(6):595-602. PubMed ID: 12522832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical use of COX-2 inhibitors].
    Ristić GG; Stefanović DZ
    Vojnosanit Pregl; 2001; 58(3):283-95. PubMed ID: 11548555
    [No Abstract]   [Full Text] [Related]  

  • 39. Blood pressure destabilization and related healthcare utilization among hypertensive patients using nonspecific NSAIDs and COX-2-specific inhibitors.
    Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC
    Am J Manag Care; 2002 Oct; 8(15 Suppl):S401-13. PubMed ID: 12416790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy, safety and potential clinical roles of the COX-2-specific inhibitors.
    van der Bijl P; van der Bijl P
    Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):17-22. PubMed ID: 14552700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.